SARS‐CoV‐2 PLpro Inhibition: Evaluating in Silico Repurposed Fidaxomicin's Antiviral Activity Through In Vitro Assessment

Overview of attention for article published in ChemistryOpen, August 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#4 of 1,329)
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Altmetric has seen 79 X posts from 79 X users, with an upper bound of 82,074 followers.

RT @HansCollin2: Un antibiótico (fidaxomicina) puede bloquear una enzima (PLpro) del virus de Covid que es clave para la replicación viral…

RT @HansCollin2: Un antibiótico (fidaxomicina) puede bloquear una enzima (PLpro) del virus de Covid que es clave para la replicación viral…

RT @HansCollin2: Un antibiótico (fidaxomicina) puede bloquear una enzima (PLpro) del virus de Covid que es clave para la replicación viral…

RT @HansCollin2: Un antibiótico (fidaxomicina) puede bloquear una enzima (PLpro) del virus de Covid que es clave para la replicación viral…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 75 additional X posts.